1,985 results match your criteria Transitional Cell Carcinoma Imaging


Primary transitional cell carcinoma of the fallopian tube: A case report and literature review.

Medicine (Baltimore) 2020 May;99(22):e20499

Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.

Introduction: Primary transitional cell carcinoma (TCC) of the fallopian tube is an extremely rare tumor.

Patient Concerns: A 79-year-old woman presenting with vaginal discharge.

Diagnosis: Pelvic magnetic resonance imaging revealed a predominantly solid mass with a lobulated contour, measuring 5. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000020499DOI Listing

Clinical value of texture analysis in differentiation of urothelial carcinoma based on multiphase computed tomography images.

Medicine (Baltimore) 2020 May;99(18):e20093

Department of Radiology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology.

Identification of histologic grading of urothelial carcinoma still depends on histopathologic examination. As an emerging and promising imaging technology, radiomic texture analysis is a noninvasive technique and has been studied to differentiate various tumors. This study explored the value of computed tomography (CT) texture analysis for the differentiation of low-grade urothelial carcinoma (LGUC), high-grade urothelial carcinoma (HGUC), and their invasive properties. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000020093DOI Listing

FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.

Jpn J Radiol 2020 Apr 3. Epub 2020 Apr 3.

Department of Radiology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.

The usefulness of whole-body 18-fluoro-2-deoxyglucose (FDG)-fluorodeoxyglucose positron emission (PET)/computed tomography (CT) is established for assessment of disease staging, detection of early disease recurrence, therapeutic evaluation, and predicting prognosis in various malignancies; and for evaluating the spread of inflammation. However, the role of FDG-PET/CT for the liver is limited because CT and magnetic resonance imaging (MRI) can provide an accurate diagnosis of most tumors. In addition, in other potentially useful roles there are several pitfalls in the interpretation of FDG uptake in PET/CT imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11604-020-00961-1DOI Listing

Bellini Duct Carcinoma Misdiagnosed with Urothelial Papillary Carcinoma.

Case Rep Oncol Med 2020 10;2020:3174674. Epub 2020 Feb 10.

Faculty of Medicine and Medical Sciences, Holy Spirit University of Kaslik (USEK), Jounieh, Lebanon.

Background: Collecting (Bellini) duct carcinoma (CDC) or Bellini duct carcinoma (BDC) is a rare subtype of kidney tumors, accounting for less than 3% and known to have the worst prognosis. It is known to have multiple clinical presentations; this is why it can be easily misdiagnosed. The aim of this article is to present a case of CDC that was initially misdiagnosed with urothelial papillary carcinoma (UPC) in a 41-year-old male. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/3174674DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035507PMC
February 2020

Primary Retroperitoneal Transitional Cell Carcinoma Identified on 18F-Fludeoxyglucose Positron Emission Tomography/Computed Tomography: An Exceedingly Rare Radio-Pathological Entity.

Indian J Nucl Med 2020 Jan-Mar;35(1):63-65. Epub 2019 Dec 31.

Department of Pathology, MIOT International Hospital, Chennai, Tamil Nadu, India.

We report here initial staging and follow-up imaging findings of a case of primary retroperitoneal transitional cell carcinoma, one of the rarest nonurological tumors of the retroperitoneal space, to highlight the importance of F-fludeoxyglucose positron emission tomography/computed tomography in this infrequently encountered pathology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijnm.IJNM_129_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958964PMC
December 2019

Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.

Neurology 2020 02 6;94(5):e521-e528. Epub 2020 Jan 6.

From the Division of Pharmacology (M.T.J.v.B., D.P., B.M.K., J.H.B., J.H.M.S.), Clinical Pharmacology (M.T.J.v.B., B.M.K., J.H.B., J.H.M.S), Division of Pathology (M.B.), Department of Biometrics (K.S.), Department of Laboratory Medicine (D.T.C.L., D.v.d.B.), and Department of Neuro-oncology (D.B.), Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam; and Science Faculty (J.H.B., J.H.M.S), Pharmaceutical Sciences, Division of Pharmaco-epidemiology and Clinical Pharmacology, Utrecht University, the Netherlands.

Objective: The primary objective was to determine the sensitivity and specificity of epithelial cell adhesion molecule (EpCAM) immunoflow cytometry circulating tumor cells (CTC) analysis in CSF in patients with suspected leptomeningeal metastases (LM). The secondary objective was to explore the distribution of driver mutations in the primary tumor, plasma, cell free CSF (cfCSF), and isolated CTC from CSF in non-small cell lung cancer (NSCLC).

Methods: We tested the performance of the CTC assay vs CSF cytology in a prospective study in 81 patients with a clinical suspicion of LM but a nonconfirmatory MRI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008751DOI Listing
February 2020

Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging.

Eur Radiol 2020 Apr 3;30(4):2103-2114. Epub 2020 Jan 3.

Academic Department of Radiology, Hôpital Pitié-Salpêtrière and Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.

Objectives: To develop technical guidelines for magnetic resonance imaging aimed at characterising renal masses (multiparametric magnetic resonance imaging, mpMRI) and at imaging the bladder and upper urinary tract (magnetic resonance urography, MRU).

Methods: The French Society of Genitourinary Imaging organised a Delphi consensus conference with a two-round Delphi survey followed by a face-to-face meeting. Two separate questionnaires were issued for renal mpMRI and for MRU. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06530-zDOI Listing

A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.

Proc Natl Acad Sci U S A 2020 01 23;117(1):563-572. Epub 2019 Dec 23.

Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095;

Small cell carcinoma of the bladder (SCCB) is a rare and lethal phenotype of bladder cancer. The pathogenesis and molecular features are unknown. Here, we established a genetically engineered SCCB model and a cohort of patient SCCB and urothelial carcinoma samples to characterize molecular similarities and differences between bladder cancer phenotypes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1915770117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955337PMC
January 2020

Esophageal Carcinosarcoma with Basaloid Squamous Cell Carcinoma: A Case Report and Review of the Literature.

Tohoku J Exp Med 2019 12;249(4):255-263

Department of Pathology, Tohoku University Graduate School of Medicine.

Esophageal carcinosarcoma is a rare tumor composed of neoplastic squamous epithelium and sarcomatous spindle cells. The origin of spindle cells remains unknown; however, the majority of sarcomatous components are currently considered to be derived from existing carcinomatous cells via epithelial-mesenchymal transition (EMT). We report a case of esophageal carcinosarcoma harboring basaloid squamous cell carcinoma successfully treated with preoperative chemotherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1620/tjem.249.255DOI Listing
December 2019

[Influence of immunomodulators on urological imaging].

Urologe A 2019 Dec;58(12):1451-1460

Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Tübingen, Tübingen, Deutschland.

Background: Immune checkpoint inhibitors (ICI) have led to great advances in the therapy of metastatic renal cell and urothelial carcinoma. Currently ICI are approved for the first-line therapy of cisplatin-unfit patients (Atezolizumab, Pembrolizumab) and second-line therapy in patients with metastasized urothelial cancer (Atezolizumab, Nivolumab, Pembrolizumab). For the therapy of metastasized RCC, Nivolumab is approved as a second-line therapy and in combination with the CTLA‑4 antibody Ipilimumab as a first-line therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-019-01063-1DOI Listing
December 2019

[A Case Of cT3bN2M0 Pleomorphic Giant Cell Carcinoma of the Bladder without Recurrence after Neoadjuvant Chemotherapy and Radical Cystectomy for 4 Years].

Hinyokika Kiyo 2019 Sep;65(9):377-380

The Department of Urology, Shimada Municipal Hospital.

Pleomorphic giant cell carcinoma of the bladder is a highly malignant subtype and its prognosis is very poor. Among 22 previously reported cases, 14 cases were diagnosed as muscle-invasive tumors and the 10 patients died within 1.5 years after the initial diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14989/ActaUrolJap_65_9_377DOI Listing
September 2019

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer.

J Am Coll Radiol 2019 Nov;16(11S):S417-S427

Specialty Chair, University of Alabama at Birmingham, Birmingham, Alabama.

Urothelial cancer is the second most common cancer, and cause of cancer death, related to the genitourinary tract. The goals of surveillance imaging after the treatment of urothelial cancer of the urinary bladder are to detect new or previously undetected urothelial tumors, to identify metastatic disease, and to evaluate for complications of therapy. For surveillance, patients can be stratified into one of three groups: (1) nonmuscle invasive bladder cancer with no symptoms or additional risk factors; (2) nonmuscle invasive bladder cancer with symptoms or additional risk factors; and (3) muscle invasive bladder cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2019.05.026DOI Listing
November 2019

Papillary squamotransitional cell carcinoma of the uterine cervix: a case report and review of the literature.

J Med Case Rep 2019 Oct 27;13(1):319. Epub 2019 Oct 27.

Department of Gynecology and Obstetrics, University Hospitals Schleswig Holstein, Campus Kiel, Arnold-Heller-Strasse 3, House 24, 24105, Kiel, Germany.

Background: Papillary squamotransitional cell carcinoma of the uterine cervix is a rare neoplasm, a subtype of transitional cervical carcinoma that appears to be a variation of squamous cervical carcinoma. It has a disposition toward metastasis at an advanced stage and local recurrence. Owing to the difficulty of illustrating the invasion histologically, misdiagnosis is likely to affect the patient's prognosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13256-019-2217-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815390PMC
October 2019
1 Read

Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma.

Urology 2020 Jan 23;135:95-100. Epub 2019 Oct 23.

Department of Urology, Mayo Clinic, Rochester, MN. Electronic address:

Objective: To better understand the safety and diagnostic yield of percutaneous core-needle biopsy (PCNB) for upper tract urothelial carcinoma (UTUC).

Methods: Of 444 patients undergoing radical nephroureterectomy (RNU) for UTUC between 2009 and 2017 at our institution, 42 who had PCNB prior to RNU were identified for analysis. Endpoints included safety, diagnostic yield, and concordance with RNU pathology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.10.005DOI Listing
January 2020

Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.

Asian Pac J Cancer Prev 2019 Oct 1;20(10):2995-3000. Epub 2019 Oct 1.

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Background: Patients with metastatic urothelial carcinoma (mUC) have an uncertain prognosis. The aim of the current study was to evaluate the prognostic potential of a skeletal muscle mass reduction index measured by computed tomography (CT) for mUC patients undergoing second-line gemcitabine and docetaxel (GD) chemotherapy.

Methods: We retrospectively reviewed 44 patients with mUC who received second-line GD chemotherapy between 2006 and 2015 in our hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.31557/APJCP.2019.20.10.2995DOI Listing
October 2019

A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging.

Nat Commun 2019 10 24;10(1):4861. Epub 2019 Oct 24.

CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, 100190, Beijing, China.

Achieving the activation of drugs within cellular systems may provide targeted therapies. Here we construct a tumour-selective cascade activatable self-detained system (TCASS) and incorporate imaging probes and therapeutics. We show in different mouse models that the TCASS system accumulates in solid tumours. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-12848-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813295PMC
October 2019
1 Read

Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profile.

Diagn Pathol 2019 Oct 21;14(1):113. Epub 2019 Oct 21.

Department of Pathology, University of Michigan Medical School, 2800 Plymouth Rd, Building 35, Ann Arbor, MI, 48109, USA.

Background: Rapid ("warm") autopsies of patients with advanced metastatic cancer provide important insight into the natural history, pathobiology and histomorphology of disease in treatment-resistant tumors. Plasmacytoid urothelial carcinoma (PUC) is a rare variant of urothelial carcinoma characterized by neoplastic cells morphologically resembling plasma cells. PUC is typically aggressive, high-stage at presentation, and associated with poor outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13000-019-0896-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802321PMC
October 2019
2 Reads

Periodically rotated overlapping parallel lines with enhanced reconstruction acquisition to improve motion-induced artifacts in bladder cancer imaging: Initial findings.

Medicine (Baltimore) 2019 Oct;98(42):e17075

Wright Center of Innovation in Biomedical Imaging, Department of Radiology.

Motion-induced artifacts have been a major drawback in bladder cancer imaging. This study is to evaluate the clinical utility of periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) acquisition in improving motion-induced artifacts in T2-weighted (T2W) magnetic resonance imaging (MRI) of bladder cancer at 3T.Sixteen patient MRI exams were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000017075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824794PMC
October 2019
1 Read

Spontaneous renoalimentary fistula as a complication of upper tract urothelial carcinoma: unknown complication of a rare disease.

BMJ Case Rep 2019 Oct 15;12(10). Epub 2019 Oct 15.

Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Fistulae of the upper urinary tract with the alimentary tract are rare. Most cases of renoalimentary fistulae are secondary to penetrating trauma, which may be iatrogenic or due to locally invasive benign infective processes or complicated nephrolithiasis, or following surgical procedures. Spontaneous renoalimentary fistulae developing secondary to locally advanced malignancies, namely renal cell carcinoma, are very rare, and unknown due to upper tract transitional cell carcinoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-231720DOI Listing
October 2019
1 Read

Diagnostic Value of F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.

Eur Urol Oncol 2020 Feb 5;3(1):73-79. Epub 2019 Oct 5.

Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address:

Background: Presence of lymph node metastases (LNM) is an important prognostic factor for cancer-specific survival (CSS) in patients with upper tract urothelial carcinoma (UTUC). In various neoplasms, F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) is an established modality for preoperative lymph node (LN) staging. In UTUC, the diagnostic value of FDG-PET/CT for LN staging is unknown. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.09.004DOI Listing
February 2020

Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.

Br J Radiol 2019 Dec 8;92(1104):20190401. Epub 2019 Oct 8.

Urology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.

Objective: To evaluate role of multiparametric MRI (mp-MRI) in differentiation between invasive and non-invasive bladder cancer and accuracy of vesical imaging reporting and data system (VI-RADS) score.

Methods And Materials: 50 patients diagnosed as cancer bladder were enrolled in this study, mp-MRI including conventional ( weighted imaging and high resolution weighted imaging) and functional sequences (diffusion-weighted imaging and dynamic contrast enhanced-MRI) were done, all data were regrouped to evaluate the accuracy of each separate sequence and mp-MRI in distinguishing non-muscle invasive from muscle-invasive tumors, with VI-RADS score application and comparison with pathological findings, then interobserver agreement for detection of muscle invasion according to mp-MRI and VI-RADS scoring system findings was calculated.

Results: Diagnostic accuracy of mp-MRI in differentiation between muscle invasive and non-muscle invasive bladder cancer was (84%) with highest sensitivity (78%), very good agreement between mp-MRI and histopathological data ( = 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20190401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913364PMC
December 2019
1 Read

Primary small cell carcinoma of the urinary bladder.

BMJ Case Rep 2019 Sep 30;12(9). Epub 2019 Sep 30.

Department of Pathology, King George's Medical University, Lucknow, Uttar Pradesh, India.

Small cell carcinoma of the urinary bladder (SCCB) is an extremely rare but aggressive tumour constituting less than 0.7% of all urinary bladder tumours. It is often misdiagnosed as transitional cell carcinoma, owing to the similarities in presentation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-230185DOI Listing
September 2019
5 Reads

Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin.

Int J Clin Oncol 2020 Jan 13;25(1):158-164. Epub 2019 Sep 13.

Division of Urology, Department of Surgery, Tottori University Faculty of Medicine, 36-1, Nishicho, Yonago, Tottori, 683-8504, Japan.

Background: To evaluate the relationship between sarcopenia and myelosuppression or between sarcopenia and survival outcomes in patients with urothelial carcinoma (UC) undergoing chemotherapy with gemcitabine plus cisplatin (GC) or carboplatin (GCa).

Methods: We evaluated 80 patients with UC who underwent chemotherapy between 2013 and 2017 at our institution. In total, 53 patients had metastatic UC and were ultimately included in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-019-01544-5DOI Listing
January 2020
1 Read

[Urothelial Carcinoma within a Calyceal Diverticulum Difficult to Distinguish from Cystic Renal Cell Carcinoma].

Hinyokika Kiyo 2019 Jul;65(7):291-294

The Department of Pathology, Osaka Police Hospital.

A 64-year-old man visited our hospital because of right renal cyst and microscopic hematuria which was found in a medical checkup. Contrast computed tomography (CT) and contrast magnetic resonance imaging (MRI) suggested cystic renal cell carcinoma. A laparoscopic nephrectomy was performed, and the surgical specimens showed urothelial carcinoma within the calyceal diverticulum. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14989/ActaUrolJap_65_7_291DOI Listing
July 2019
1 Read

Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy.

World J Urol 2020 Jun 30;38(6):1509-1515. Epub 2019 Aug 30.

Department of Urology, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.

Purpose: To evaluate the diagnostic accuracy of a second look narrow-band imaging (NBI) cystoscopy in the follow-up of patients with NMIBC as compared to a second white light cystoscopy (WLI).

Patients And Methods: From August 2013 to October 2014, 600 patients with history of non-muscle invasive bladder cancer (NMIBC), who presented for follow-up cystoscopy at an academic outpatient clinic, were randomized to flexible WLI-cystoscopy plus second look NBI-cystoscopy (n = 300) or flexible WLI-cystoscopy plus second look WLI-cystoscopy (n = 300) in the same session. We analysed the detection rate of bladder tumours in second look cystoscopy as primary endpoint. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02926-0DOI Listing
June 2020
1 Read

[Clinicopathological features of ovarian Brenner tumors].

Zhonghua Bing Li Xue Za Zhi 2019 Aug;48(8):615-619

Department of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, China.

To investigate the clinicopathological characteristics and diagnosis of ovarian Brenner tumors. Forty-seven cases of ovarian Brenner tumors were enrolled from January 2012 to May 2018 at Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Clinical data, imaging examination, histopathological characteristics and immunohistochemical phenotype were analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0529-5807.2019.08.006DOI Listing
August 2019
2 Reads

[Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma].

Beijing Da Xue Xue Bao Yi Xue Ban 2019 Aug;51(4):665-672

Department of Urology, Peking University Third Hospital, Beijing 100191, China.

Objective: To investigate the impact of preoperative diagnostic ureteroscopy and biopsy (UB) on radical nephroureterectomy (RNU) and the prognosis of upper tract urothelial carcinoma (UTUC).

Methods: The clinical data of UTUC patients receiving RNU between Jan. 2007 and Dec. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.19723/j.issn.1671-167X.2019.04.012DOI Listing
August 2019
2 Reads

Bilateral Diffuse Uveal Melanocytic Proliferation Associated With Bladder Cancer: A Novel Imaging Finding.

Ophthalmic Surg Lasers Imaging Retina 2019 08;50(8):525-528

The authors report a case of bilateral diffuse uveal melanocytic proliferation associated with transitional cell carcinoma of the bladder. A novel imaging finding on indocyanine green angiography of a "string of sausages" pattern in the large choroidal vessels is described. This occurs in areas of alternating retinal pigment epithelial hypertrophy and destruction, which is likely to be its cause. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3928/23258160-20190806-10DOI Listing

Urothelial Carcinoma of the Bladder With a Rare Solitary Metastasis to the Ovary.

Urology 2020 Jan 7;135:24-27. Epub 2019 Aug 7.

Department of Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.07.028DOI Listing
January 2020

Advanced urothelial cancer: a radiology update.

Abdom Radiol (NY) 2019 12;44(12):3858-3873

Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

The recent genomic characterization of urothelial carcinoma by the Cancer Genome Atlas Project, made possible by the introduction of high throughput, reduced cost, and sequence analysis, has shed new insights on the biology of advanced disease. In addition, studies on imaging of advanced urothelial carcinoma have widened the knowledge on disease presentation and on pattern of metastatic spread and their correlation with the underlying biology of urothelial carcinoma. The wide range of treatments for advanced urothelial cancer, including combined chemotherapy regimens and immune checkpoint inhibitors, each result in treatment class-specific patterns of response and adverse events. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-019-02148-3DOI Listing
December 2019
2 Reads

Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening.

Clin Lung Cancer 2019 11 18;20(6):429-434. Epub 2019 Jun 18.

The Legacy Heritage Center and Dr Larry Norton Institute, Soroka Medical Center, Beer Sheva, Israel; Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. Electronic address:

Background: Smoking is a major risk factor for lung cancer (LC) and transitional cell carcinoma of the bladder (TCC). Current recommendations for LC screening do not include TCC as a risk factor for determining screening eligibility. In this study we aimed to evaluate whether TCC patients constitute a population who might benefit from LC screening. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304193015
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2019.06.010DOI Listing
November 2019
5 Reads

Outcomes following balloon dilation for management of urethral obstruction secondary to urothelial carcinoma in dogs: 12 cases (2010-2015).

J Am Vet Med Assoc 2019 08;255(3):330-335

Objective: To describe outcomes for dogs that underwent balloon dilation for palliative treatment of urethral obstruction caused by urothelial carcinoma.

Animals: 12 client-owned dogs.

Procedures: Medical records were searched to identify dogs with urothelial (bladder, urethra, or prostate) carcinoma that underwent balloon dilation for treatment of urethral obstruction between April 2010 and December 2015. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2460/javma.255.3.330DOI Listing
August 2019
1 Read

Metastatic plasmacytoid bladder cancer causing malignant priapism.

BMJ Case Rep 2019 Jul 1;12(7). Epub 2019 Jul 1.

Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

An 81-year-old man presented to medical services with pelvic pain and evolving urinary retention over 3 months. The patient was found to have a tense glans and penile shaft with surrounding induration consistent with malignant priapism. The extent of the induration included the suprapubic region, scrotum, left iliac region and left flank. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-228088DOI Listing
July 2019
6 Reads

A Case Report of Atezolizumab Induced Tumor Lysis Syndrome.

Am J Case Rep 2019 Jun 4;20:785-789. Epub 2019 Jun 4.

Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA, USA.

BACKGROUND Advanced urothelial carcinoma has been associated with poor prognosis due to high resistance to chemotherapy and radiation until immunotherapeutic agents, such as atezolizumab, emerged as an option and have shown improved survival. However, atezolizumab is associated with side effects, which were mainly autoimmune. In this case study, we report on a rare case of atezolizumab-induced tumor lysis syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.915351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561135PMC
June 2019
8 Reads

Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.

Vet Radiol Ultrasound 2019 Sep 29;60(5):552-559. Epub 2019 May 29.

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.

Feline transitional cell carcinoma (TCC) is a rare neoplasia of cats with an estimated prevalence of 0.18%. Cats with TCC share clinical signs with common pathologies like feline idiopathic cystitis or urinary tract infections. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vru.12777DOI Listing
September 2019
5 Reads

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.

J Vis Exp 2019 05 12(147). Epub 2019 May 12.

Laboratory of Translational Cancer Research, Institute for Translational Research, Ochsner Clinic Foundation; Ochsner Clinical School, University of Queensland, School of Medicine;

Cancer patients have poor prognoses when lymph node (LN) involvement is present in both high-grade urothelial cell carcinoma (HG-UCC) of the bladder and colorectal cancer (CRC). More than 50% of patients with muscle-invasive UCC, despite curative therapy for clinically-localized disease, will develop metastases and die within 5 years, and metastatic CRC is a leading cause of cancer-related deaths in the US. Xenograft models that consistently mimic UCC and CRC metastasis seen in patients are needed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59223DOI Listing
May 2019
5 Reads

URINARY BLADDER TRANSITIONAL CELL CARCINOMA AND CARCINOMATOSIS IN A LINNAEUS'S TWO-TOED SLOTH, .

J Zoo Wildl Med 2019 03;50(1):278-281

Vancouver Aquarium Marine Science Center, Vancouver, BC,V6G 3E2, Canada.

A 19-yr-old female Linnaeus's two-toed sloth () with a history of urinary incontinence, ascites, and behavioral changes was euthanized after diagnostic imaging revealed a large bladder mass. On gross necropsy, the sloth had a severely thickened bladder mucosa, partial urinary obstruction, and nonseptic exudate in the peritoneal cavity. Histopathology showed a malignant and highly invasive transitional cell (urothelial) carcinoma with transmural and intra-abdominal invasion and diffuse carcinomatosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1638/2018-0059DOI Listing
March 2019
21 Reads

Urothelial carcinoma in children, case report with review of literature.

J Pak Med Assoc 2019 May;69(5):720-721

Urology Department, The Indus Hospital, Karachi, Pakistan.

Urothelial carcinoma is the third most prevalent malignancy in adults, accounting for 2.1 % of all cancerrelated deaths. The highest incidence in the 6th decade of life but it is rare in the paediatric population and its incidence is less than 1% constituting a very rare disease. Read More

View Article

Download full-text PDF

Source

EDITORIAL COMMENT.

Authors:
Harry Herr

Urology 2019 06;128:60

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.01.040DOI Listing

[A Case of Small Cell Carcinoma of the Renal Pelvis].

Hinyokika Kiyo 2019 Feb;65(2):39-43

The Department of Urology, Japan Community Health-Care Organization Hoshigaoka Medical Center.

A 84-year-old female visited our hospital with the chief complaint of asymptomatic gross hematuria. The computed tomography and magnetic resonance imaging revealed a large invasive tumor in the right renal pelvis. Metastatic workup was negative. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14989/ActaUrolJap_65_2_39DOI Listing
February 2019
26 Reads

Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma.

Can J Urol 2019 04;26(2):9743-9745

Transitional Year Program, Riverside Regional Medical Center, Newport News, Virginia, USA.

Renal cell carcinoma (RCC) is usually treated with surgery, with or without systemic therapy. For select patients, stereotactic body radiation therapy (SBRT) may be a suitable alternative. Although many reports exist on the successful use of SBRT, very few have described long term outcomes with regard to disease progression and renal function. Read More

View Article

Download full-text PDF

Source
April 2019
10 Reads

Survival analysis in dogs with urinary transitional cell carcinoma that underwent whole-body computed tomography at diagnosis.

Vet Comp Oncol 2019 Sep 13;17(3):385-393. Epub 2019 Jun 13.

Laboratory of Veterinary Clinical Oncology, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.

This retrospective study aimed to evaluate factors associated with survival and to compare characteristics between tumour localizations in dogs with urinary transitional cell carcinoma (TCC) that underwent whole-body computed tomography (CT) at diagnosis. Dogs with histologically confirmed TCC that received medical therapy between 2010 and 2017 were included; dogs that underwent surgery or radiotherapy for the primary tumour were excluded. According to the CT findings, primary tumour localization (classified into the Bladder, Urethra and Bladder and Urethra groups), prostate involvement, iliosacral lymphadenomegaly, sternal lymphadenomegaly and metastasis to the bone and lung were evaluated for survival analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/vco.12483DOI Listing
September 2019
4 Reads

An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.

Medicine (Baltimore) 2019 Apr;98(16):e15245

Department of Comprehensive Internal Medicine, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning.

Rationale: Urothelial carcinoma, also named transitional cell carcinoma, is the most frequent occurring malignancy in the urinary system. It mainly invades the surrounding tissues and metastasizes to distant organs in later stages.

Patient Concerns: Here, we presented an unusual case of occult urothelial carcinoma primarily manifested as a multiorgan metastatic cancer in a 59-year-old man. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000015245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494344PMC
April 2019
4 Reads
5.723 Impact Factor

YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis.

J Pathol 2019 08 29;248(4):476-487. Epub 2019 Apr 29.

Human Genetic Center, China Medical University Hospital, Taichung, Taiwan.

The objective of this study was to characterize the oncogenic actions of a recently identified cancer-associated gene YWHAZ (also named as 14-3-3 ζ/δ) in urothelial carcinomas of the urinary bladder (UCUB). A genome-wide study revealed YWHAZ to be involved in the amplicon at 8q22.3, and its genetic amplification was detected predominantly in muscle-invasive bladder cancer (MIBC). Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/path.5274
Publisher Site
http://dx.doi.org/10.1002/path.5274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767422PMC
August 2019
19 Reads

High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.

Urology 2019 07 28;129:146-152. Epub 2019 Mar 28.

Department of Urology, NYU Langone Health, New York, NY. Electronic address:

Objective: To evaluate the impact of cisplatin-based neoadjuvant chemotherapy (NAC) in patients who underwent nephroureterectomy for high-grade (HG) upper tract urothelial carcinoma (UTUC).

Methods: Retrospective review was conducted of patients with HG UTUC from 2011 to 2017 who underwent nephroureterectomy at 2 institutions. Patients with eGFR >50 mL/min/1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.01.058DOI Listing
July 2019
6 Reads

Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma.

World J Urol 2019 Nov 26;37(11):2271-2278. Epub 2019 Mar 26.

Division of Urology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Purpose: To summarize knowledge on upper urinary tract carcinoma (UTUC) regarding diagnostic procedures, risk factors and prognostic markers.

Methods: A scoping review approach was applied to search literature in Pubmed, Web of Science, and Embase. Consensus was reached through discussions at Consultation on UTUC in Stockholm, September 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02732-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825655PMC
November 2019
6 Reads

Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma.

Int Braz J Urol 2019 Jul-Aug;45(4):843-846

Department of Urology, Istanbul Bilim University, Istanbul, Turkey.

Introduction: Cancer is one of the most important leading cause of death in man and woman in the world. The occurrence of new cancer has become more frequent in recent years due to strict screening protocols and occupational and environmental exposure to carcinogens. The incidence of secondary malignancies has also increased due to close medical follow-up and advanced age. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837587PMC
September 2019
6 Reads

The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.

Kidney Int 2019 04;95(4):1001-1002

Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.11.017DOI Listing
April 2019
1 Read

Staging a great escape -Incidentally detected renal urothelial carcinoma with extensive squamous metaplasia presenting as pyonephrosis.

J Cancer Res Ther 2019 Mar;15(Supplement):S159-S162

Department of Surgery, Maulana Azad Medical College, New Delhi, India.

Incidentally, detected upper urinary tract urothelial carcinoma is a rare entity. We report the case of a 70-year-old female patient who presented with flank pain, pyuria, fever, and a unilateral nonfunctioning kidney with nephrolithiasis and pyonephrosis on pyelography. Routine imaging failed to identify a mass lesion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jcrt.JCRT_628_17DOI Listing
March 2019
8 Reads

The Impact of Narrow Band Imaging in the Detection and Resection of Bladder Tumor in Transitional Cell Carcinoma of the Bladder: A Prospective, Blinded, Sequential Intervention Randomized Controlled Trial.

Urology 2019 06 26;128:55-61. Epub 2019 Feb 26.

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Objective: To determine the impact of Narrow Band Imaging (NBI) in detection and resection of tumors during transurethral resection of bladder cancer.

Materials And Methods: This was a single center randomized prospective interventional study with a sequential intervention design. Patients with bladder tumors were randomized into 2 arms where they were resected under white light (WL) first followed by NBI in arm A, or NBI followed by WL in arm B. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.01.039DOI Listing
June 2019
12 Reads